Skip to main content

Table 3 Associations between the response of induction chemotherapy and clinicopathologic parameters in 162 smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with TPF

From: Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

Parameters

 

Response to induction chemotherapy

  

CR/PR

SD/PD

P value

Age

<53 years old

47

34

0.42

 

≧53 years old

52

29

 

Sex

Male

96

60

0.68

 

Female

3

3

 

Clinical 7th AJCC stage

IVA

47

33

0.54

 

IVB

52

30

 

Clinical T classification

T1~T4a

55

37

0.69

 

T4b

44

26

 

Clinical N classification

N0/1

35

13

0.045*

 

N2/3

64

50

 

Primary tumor site

Oral cavity

35

27

0.34

 

Others

64

36

 

Primary tumor site

Oropharynx

40

20

0.27

 

Others

59

43

 

Primary tumor site

Larynx/hypopharynx

23

13

0.70

 

Others

76

50

 

Alcohol

Absent

10

6

0.90

 

Present

89

57

 

Betel nut chewing

Absent

24

7

0.038*

 

Present

75

56

 
  1. TPF docetaxel, cisplatin, and fluorouracil; CR complete response; PR partial response; SD stable disease; PD progression disease
  2. *Statistically significant. х 2 test, Fisher’s exact test, or t test was used for statistically analyzed